Ulcerative colitis is a type of inflammatory bowel disease characterised by diffuse inflammation of the colonic mucosa and a relapsing, remitting course.
Patients commonly experience bloody diarrhoea, chronic diarrhoea (or both), lower abdominal pain, faecal urgency, and extraintestinal manifestations, particularly those related to activity of the colitis.
Diagnosis requires endoscopy with biopsy and negative stool culture.
Relapses are often associated with pathogens; therefore, stool should be obtained for culture in all cases of disease flare-up.
Treatment aims to induce and maintain remission. Drug choice and formulation depends on the severity and extent of disease.
Toxic megacolon can occur with associated risk of perforation. Bowel adenocarcinoma is a complication in 3% to 5% of patients.
Ulcerative colitis (UC) is a type of inflammatory bowel disease that characteristically involves the rectum and extends proximally to affect a variable length of the colon. It is recognised as a multifactorial polygenic disease, as the exact aetiology is still unknown. Included in the aetiological theories are environmental factors, immune dysfunction, and a likely genetic predisposition.   
Research Fellow in Gastroenterology
St George's Hospital
BS declares that he has no competing interests.
Department of Gastroenterology
St George’s Hospital
AP is an author of a reference cited in this topic.
Dr Ben Shandro and Dr Andrew Poullis would like to gratefully acknowledge Dr Anet Soubieres, Dr Rhys Hewett, Dr Willem J.S. de Villiers, and Dr Houssam Mardini, previous contributors to this topic.
Associate Professor of Medicine
Division of Digestive Diseases and Nutrition
University of Kentucky
TW declares that he has no competing interests.
Assistant Professor of Surgery
Division of Colon and Rectal Surgery
University Hospital Case Medical Center
SS received a fee for educational courses on laparoscopic surgery, paid for in part by Covidien, Olympus, and Applied Medical.
Use of this content is subject to our disclaimer